LASIK Treatment — Cost, Top Hospitals & Success Rates | MyMedicPlus

LASIK (Laser-Assisted In Situ Keratomileusis) is best understood not only as a surgical procedure but as a permanent vision correction treatment — one that replaces the optical function of spectacles or contact lenses by reshaping the patient's own cornea. This guide focuses on what LASIK corrects, how well it corrects it, how it compares with the alternatives, and what patients can expect from their vision over a lifetime following treatment.

The fundamental principle of LASIK treatment is corneal reshaping. The human cornea accounts for approximately 70% of the eye's total refractive power (approximately 43 dioptres of a typical 60-dioptre total). By selectively removing microscopic amounts of stroma — typically 12–13 µm per dioptre of myopic correction — the excimer laser alters the anterior corneal curvature and thereby changes the eye's optical power. This change is permanent: the removed tissue does not regenerate. What patients sometimes experience as regression is not the cornea reverting to its original shape but rather the natural crystalline lens and axial length continuing to change with age.

LASIK's primary advantage over spectacle and contact lens correction is not merely convenience — quality-of-life research consistently shows that spectacle- and contact lens-wearers score lower on visual function questionnaires than LASIK-treated patients, primarily because corrective lenses are imperfect optical substitutes for a naturally corrected cornea. LASIK-treated eyes, when compared to matched spectacle-corrected controls, demonstrate measurably better contrast sensitivity in low-light conditions, superior peripheral vision, and reduced chromatic aberration.

LASIK provides effective correction across a clinically useful range of refractive errors. Understanding the nuances of what is treatable helps patients set realistic expectations:

Myopia (Short-Sightedness)

LASIK is most effective and most stable for myopia treatment. FDA approvals in the United States extend to approximately -12.00 dioptres (D) of myopia. However, the optimal treatment range where outcomes are most stable and regression least common is -1.00 D to -8.00 D. For corrections above -8.00 D, more stroma must be removed, increasing the risk of insufficient residual stromal bed, corneal weakening, and long-term regression. High myopes (-8.00 D to -12.00 D) should receive careful counselling about higher regression rates and be offered phakic intraocular lens (EVO ICL) as an alternative that does not require corneal tissue removal.

Hyperopia (Long-Sightedness)

LASIK for hyperopia is approved up to approximately +6.00 D. Hyperopic LASIK works by steepening the peripheral cornea rather than flattening the central cornea, which is a less stable ablation pattern due to the peripheral healing response. Patients with high hyperopia (+4.00 D to +6.00 D) are at greater risk of regression — meaning partial return of their prescription over 1–5 years — compared to myopic LASIK. For this reason, hyperopic patients above +3.00 D should be counselled that enhancement retreatment may be needed, and refractive lens exchange (RLE) is often preferred in patients over 45 with high hyperopia.

Astigmatism

LASIK effectively treats astigmatism up to approximately ±6.00 D cylinder. In practice, corrections up to ±3.00 D cylinder achieve highly predictable outcomes; higher cylinder corrections carry somewhat greater residual astigmatism risk. Topography-guided LASIK (Contoura Vision) has demonstrated superior residual astigmatism outcomes compared to wavefront-optimised ablation in several comparative studies and is the preferred ablation profile for patients with significant irregular astigmatism.

Mixed Refractive Errors

Most patients present with a combination of sphere and cylinder. For example, a prescription of -4.00 D sphere with -2.00 D cylinder is a straightforward combined myopia and astigmatism correction that LASIK handles well. The excimer laser calculates a combined toric ablation profile that addresses both components simultaneously.

Not all patients with refractive errors are suitable for LASIK. The pre-treatment evaluation determines suitability based on a combination of refractive, anatomical, and general health criteria:

Core Eligibility Criteria

• Age 21 or older with documented stable refraction for at least 12 months (two spectacle or contact lens prescriptions from the same optometrist, at least 1 year apart, showing less than 0.50 D change)
• Corneal thickness of at least 500 µm measured by Scheimpflug imaging (Pentacam) or ultrasound pachymetry, ensuring adequate tissue remains after flap creation and ablation (minimum residual stromal bed: 250 µm)
• Normal corneal topography — no signs of keratoconus, pellucid marginal degeneration, or other progressive ectatic disease
• Adequate tear film — mild dry eye can be managed peri-operatively, but severe dry eye is a contraindication
• No systemic autoimmune disease that would impair corneal wound healing (lupus, rheumatoid arthritis, Sjogren syndrome)

Age and Lifestyle Considerations

Patients in their 20s and early 30s are ideal candidates. Patients over 40 must be counselled about presbyopia management (see section below). Patients with vocational requirements excluding monovision (pilots, professional drivers) should be directed toward bilateral emmetropic LASIK with the understanding they will require reading glasses for near tasks after the age of 40–45.

The Pre-Treatment Workup

A comprehensive pre-LASIK evaluation (typically 1–2 hours) includes: manifest and cycloplegic refraction; Scheimpflug corneal tomography (anterior and posterior surface elevation maps, corneal thickness map); wavefront aberrometry; tear film assessment (TBUT, Schirmer test, meibomian gland evaluation); pupillometry in mesopic and scotopic conditions; and slit-lamp examination of the anterior and posterior segments. This data determines not only eligibility but also which laser platform and ablation profile will achieve the best individual result.

LASIK treatment is not one-size-fits-all. Ablation profiles and treatment strategies are customised based on age, prescription, corneal anatomy, and lifestyle goals:

Standard Bilateral Distance Correction

Both eyes are corrected to emmetropia (plano, or zero prescription) for optimal distance vision. This is the most common LASIK treatment plan for patients under 40. The visual outcome is best-in-class binocular distance vision, typically achieving 20/20 or better in over 90% of patients. The trade-off for patients over 40 is dependence on reading glasses for near tasks, as the natural crystalline lens has lost or is losing its accommodation (ability to focus at near). This is not a complication of LASIK — it is the natural progression of presbyopia that would have required reading glasses regardless of LASIK.

Monovision LASIK (Blended Vision)

The most widely used strategy for presbyopic LASIK patients. The dominant eye is corrected to plano (for distance) and the non-dominant eye is under-corrected to approximately -1.25 D to -1.75 D (for intermediate and near tasks). The brain learns to use the appropriate eye for the appropriate distance, with most patients achieving functional spectacle independence for both distance and near activities. Approximately 80% of monovision LASIK patients adapt successfully. A mandatory monovision contact lens trial (1–2 weeks) before committing to surgical monovision is strongly recommended to assess tolerance, particularly for patients with high binocularity demands (competitive driving, sport, or occupations requiring precise distance judgment).

PresbyMax / SUPRACOR (Multifocal Ablation)

Multifocal corneal ablation profiles create a central near-reading zone within the ablation optical zone while maintaining a peripheral distance-correction zone, analogous to a multifocal contact lens. PresbyMax (SCHWIND AMARIS platform) and SUPRACOR (Technolas laser) are the most established platforms. Published results show spectacle independence for distance and near in 70–80% of patients. Disadvantages include increased risk of halos and reduced contrast sensitivity compared to standard LASIK. These profiles are not available on all laser platforms and are not FDA-approved for presbyopia indication in the United States, though they are available in Europe, Asia, and Latin America.

Enhancement Retreatment

LASIK enhancement (retreatment) is performed when: residual refractive error exceeds the patient's functional tolerance (typically >0.75 D residual sphere or cylinder); myopic regression returns measurable prescription change after an initially successful result; or one eye achieves excellent correction but the other has significant residual error. Lifetime retreatment rates are 5–10%, with higher rates in high myopes and hyperopes. Enhancement involves either re-lifting the original LASIK flap (possible in most cases even years later) or performing surface ablation (PRK) over the LASIK interface if the flap cannot be safely re-lifted or residual stromal bed is marginal. Residual bed thickness after enhancement must again meet the 250 µm minimum.

The case for LASIK treatment extends beyond convenience to measurable improvements in visual quality and daily function:

• Spectacle independence: Greater than 95% of patients are spectacle-free for distance vision at 1 year after LASIK for low-to-moderate myopia. Bilateral distance spectacle independence rates of 88–92% are maintained at 10-year follow-up in published registry studies.
• Quality of life metrics: The NEI Refractive Error Quality of Life (NEI-RQL-42) instrument consistently shows LASIK patients score significantly higher than spectacle or contact lens users on domains of glare, near vision, dependence on correction, and appearance concerns.
• Contact lens complication elimination: Long-term soft contact lens wearers have a 1-in-500 annual risk of microbial keratitis — a potentially vision-threatening infection. Eliminating contact lens wear through LASIK removes this cumulative lifetime risk.
• Sports and activity freedom: Patients who participate in swimming, contact sports, and outdoor activities benefit substantially from not wearing corrective devices. Post-LASIK patients with non-contact sports backgrounds can typically resume normal activity within 1 week.
• Long-term stability: For corrections below -6.00 D, the mean regression over 10 years is less than 0.50 D — clinically insignificant for the majority of patients. High myopes (>-8.00 D) may experience greater regression but typically maintain the majority of their correction benefit.
• Cost-effectiveness over time: Factoring in lifetime spectacle lens, contact lens, and associated costs, most health economic analyses show LASIK becomes cost-effective compared to ongoing lens correction within 5–7 years for moderate myopes in high-income countries.

Understanding realistic limitations ensures patient satisfaction post-treatment:

Presbyopia is Not Corrected by Standard LASIK

The most frequent source of patient disappointment is the development of reading-vision difficulty after LASIK in patients who did not understand that presbyopia is an age-related change of the crystalline lens — entirely independent of corneal correction. A 45-year-old who achieves perfect 20/20 distance vision after LASIK will still need reading glasses for near tasks due to presbyopia. Thorough pre-operative counselling on this point is essential.

Regression

All forms of LASIK carry some regression risk — the gradual return of partial prescription over months to years as the cornea and lens undergo age-related changes. Regression is more common and more pronounced with high myopic correction (>-6.00 D) and hyperopic correction. Patients treated in their early 20s may notice mild regression by their 30s as natural lens-related myopic shift occurs. Enhancement retreatment is effective when adequate residual stromal tissue remains.

Night Vision Disturbances

Halos, glare, and starbursting around lights at night are reported by 15–25% of patients in the first 3 months. For most patients these resolve as the brain adapts to the new optical profile. Persistent, clinically significant night-vision symptoms occur in approximately 1–3%. Risk is higher in patients with large scotopic pupil diameters exceeding the ablation optical zone and in patients who received conventional (non-wavefront) LASIK. Modern wavefront-guided and topography-guided profiles reduce this risk substantially.

Post-LASIK Corneal Map Changes and IOL Implications

A critically important long-term consideration: LASIK permanently changes the anterior corneal surface in a way that invalidates standard intraocular lens (IOL) power calculation formulas used for cataract surgery. Standard formulas (SRK/T, Holladay 1) rely on keratometry (corneal curvature measurement) that is systematically underestimated after myopic LASIK. If these formulas are used for cataract surgery without LASIK correction, the implanted IOL will be systematically underpowered, leaving the patient hyperopic. LASIK patients must inform their cataract surgeon of their pre-LASIK prescription and LASIK date, as LASIK-adjusted formulas (Barrett True-K, Haigis-L, Kane) must be used for accurate IOL selection. Pre-LASIK keratometry records are valuable for future cataract surgery planning.

Dry Eye and Visual Fluctuation

15–20% of patients experience significant dry eye in the first 3–6 months, causing fluctuating vision (particularly in air-conditioned environments). Most resolve with artificial tears and time. Screen-dependent occupations (software engineers, office workers) may experience particular difficulty in the early post-operative period. Omega-3 supplementation, preservative-free artificial tears, and warm lid massage are first-line management.

Understanding the LASIK treatment timeline helps patients plan their return to normal activities and set appropriate visual recovery expectations:

Day of Treatment

Both eyes are treated in the same session (bilateral simultaneous LASIK in 98% of cases). The procedure itself takes 10–15 minutes per eye. Patients experience mild discomfort, tearing, and light sensitivity for 4–6 hours post-treatment. Vision is blurry immediately after, as if underwater, but clears substantially by evening. A protective eye shield is worn during sleep on the first night to prevent accidental rubbing, which could displace the flap.

Days 1–7

Most patients achieve functional distance vision by the morning of day 1. Legal driving vision (20/40 or better) is achieved in over 90% of patients by day 1. Full distance clarity typically stabilises within 1–2 weeks for low-to-moderate myopia corrections. Patients may notice fluctuating vision throughout the day during this period — this is normal and improves as the corneal epithelium stabilises over the flap edge and the tear film normalises.

Weeks 2–4

Visual fluctuation decreases. Reading vision (for patients under 40) typically recovers alongside distance vision. Patients with higher prescriptions may notice slightly slower stabilisation. Dry eye symptoms typically peak in weeks 2–4 then gradually improve.

3–6 Months

Refractive stability is assessed at the 3-month visit — this is the earliest point at which enhancement candidacy can be determined if residual refractive error is present. Most patients' prescriptions have stabilised by month 3; high myopes may continue stabilising until month 6. Night vision disturbances typically plateau by 3 months and then gradually resolve.

1 Year and Beyond

The 12-month result is considered the definitive LASIK outcome. Annual follow-up is advisable for patients with high corrections or borderline pre-operative corneas. Patients should inform all future eye care providers (optometrists, cataract surgeons) that they have had LASIK, provide their pre-LASIK prescription if known, and ensure LASIK-adjusted formulas are used for future IOL calculations.

LASIK treatment involves a single upfront cost that, when compared to the cumulative lifetime cost of spectacles and contact lenses, typically represents net cost savings over a 7–10 year period:

Understanding the All-Inclusive Package vs. Per-Session Pricing

Reputable LASIK centres quote a per-eye all-inclusive price that covers: pre-operative workup, the surgical procedure itself, post-operative medications (antibiotic and steroid drops), and all follow-up visits for a defined period (typically 1 year). Some centres offer a lifetime enhancement guarantee — a significant value if regression requires retreatment. Patients should verify exactly what is included when comparing prices across centres.

Technology Premium

Femtosecond IntraLASIK (bladeless) carries a premium over microkeratome LASIK of approximately USD 200–500 per eye. Topography-guided (Contoura) or wavefront-guided ablation carries an additional USD 200–400 per eye premium over standard wavefront-optimised treatment. These premiums are generally justified by measurably better outcomes for specific patient populations.

Global Cost Comparison

• India: INR 20,000–80,000 per eye (USD 240–960). Top-tier femtosecond LASIK at Aravind, Sankara Nethralaya, or LV Prasad Eye Institute centres: INR 50,000–80,000.
• United States: USD 1,500–3,500 per eye. Average USD 2,200 for all-laser wavefront LASIK.
• United Kingdom: GBP 1,200–2,500 per eye (private; LASIK is not covered by the NHS).
• Turkey (medical tourism): USD 600–1,500 per eye at internationally accredited centres (Istanbul).
• Thailand (medical tourism): USD 800–1,800 per eye at Bangkok Samitivej, Bangkok International Eye Clinic.
• Mexico (medical tourism): USD 700–1,600 per eye at major cities (Mexico City, Monterrey).

Lifetime Cost Comparison

A comprehensive contact lens wearer in a high-income country typically spends USD 500–900 per year on lenses, solutions, and check-ups. Over 20 years this amounts to USD 10,000–18,000. LASIK at USD 4,000–6,000 for both eyes therefore represents significant lifetime savings for most contact lens wearers, not accounting for the quality-of-life premium or the elimination of infection risk.

Patients considering LASIK should understand how it compares with the most relevant alternatives to make an informed, personalised decision:

LASIK vs. PRK (Photorefractive Keratectomy)

PRK is the flapless, surface ablation predecessor of LASIK using the same excimer laser but removing the epithelium rather than creating a flap. Long-term visual outcomes are identical at 12 months. PRK is preferred for: thin corneas where LASIK residual stromal bed would be marginal; patients at high risk of eye trauma (military, contact sport athletes) where a LASIK flap could be dislodged; and patients with significant pre-existing dry eye. The primary disadvantage of PRK is a more uncomfortable recovery (4–5 days of significant eye discomfort while the epithelium heals) and slower visual rehabilitation (1–3 weeks to achieve functional vision vs. 24–48 hours for LASIK).

LASIK vs. SMILE

SMILE (Small Incision Lenticule Extraction) is a flapless, all-femtosecond procedure where a corneal lenticule is extracted through a small incision rather than creating a flap and ablating with an excimer laser. Advantages of SMILE over LASIK: significantly less dry eye (the smaller incision severs far fewer corneal nerves); no flap (no dislocation risk); preservation of stronger anterior corneal biomechanical stiffness. Disadvantages: SMILE is currently approved for myopia and myopic astigmatism only (not hyperopia); enhancement retreatment is more complex; the correction range is limited to approximately -10.00 D myopia. SMILE has become the preferred modality for active patients with dry eye-susceptible professions and contact sport athletes.

LASIK vs. EVO ICL (Implantable Collamer Lens)

EVO ICL is an intraocular implant placed between the iris and the natural lens, avoiding corneal tissue removal. It is preferred for: patients with myopia beyond -8.00 D; thin corneas unsuitable for LASIK; patients with significant dry eye; and patients who want a reversible correction. EVO ICL achieves excellent visual outcomes — in comparative studies, high myopes (-6.00 D to -18.00 D) treated with EVO ICL have better uncorrected visual acuity and higher contrast sensitivity than LASIK-treated peers. The trade-off is an intraocular procedure (higher risk category than corneal surgery) requiring regular IOP monitoring and assessment for early cataract formation.

LASIK vs. Spectacles

Spectacles remain the safest, most reversible, and most accessible form of refractive correction. They carry no surgical risk. Modern high-index lenses with anti-reflection coating provide very good optical quality. However, spectacles have optical limitations (prismatic distortion at high powers, restricted peripheral field), lifestyle restrictions (fogging, breakage), and evidence shows slightly lower visual function scores on validated questionnaires compared to LASIK-treated patients in the same prescription range.

LASIK vs. Contact Lenses

Daily disposable contact lenses provide excellent optical quality and offer no surgical risk. However, they carry a cumulative infection risk (1-in-500 annual microbial keratitis risk for daily wear soft lenses; higher for extended wear). Over 40 years of wearing contact lenses, a contact lens-associated severe infection event is a meaningful probability. LASIK eliminates this cumulative risk while providing superior optical quality in low-contrast and mesopic conditions based on contrast sensitivity measurements.